Point72 Asset Management
IPXL

Point72 Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Point72 Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,006,453
Closed -$20.4M – 1206
2017
Q3 		$20.4M Sell
1,006,453
-736,125
-42% -$14.1M 0.09% 260
2017
Q2 		$28.1M Buy
1,742,578
+646,978
+59% +$9.56M 0.16% 174
2017
Q1 		$13.9M Buy
1,095,600
+514,200
+88% +$6.21M 0.08% 326
2016
Q4 		$7.7M Buy
581,400
+14,900
+3% +$255K 0.05% 371
2016
Q3 		$13.4M Buy
+566,500
New +$15.2M 0.09% 240
2015
Q4 		– Sell
-59,700
Closed -$2.1M – 932
2015
Q3 		$2.1M Sell
59,700
-123,300
-67% -$5.56M 0.02% 551
2015
Q2 		$8.4M Buy
+183,000
New +$8.69M 0.06% 355

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Point72 Asset Management's IPXL Position: Q4 2017 in Review

Point72 Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 1,006,453 shares — an estimated $20.4M sold.

Point72 Asset Management first reported a position in IPXL in Q2 2015 and held it in 7 quarters. The position peaked at $28.1M in Q2 2017. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Point72 Asset Management reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Point72 Asset Management sold 1,006,453 Impax Laboratories, Inc. shares in Q4 2017, an estimated $20.4M.
  • Point72 Asset Management first reported a position in Impax Laboratories, Inc. in Q2 2015 and held it in 7 quarters.
  • Point72 Asset Management's Impax Laboratories, Inc. position peaked at $28.1M in Q2 2017.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Point72 Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.